Ifosfamide-induced encephalopathy: Brand-name (HOLOXAN (R)) vs generic formulation (IFOSFAMIDE EG (R))

Chambord, J; Henny, F; Salleron, J; Hombourger, B; Lider, P; Vigneron, J; Demore, B; Vallance, C; Rios, M

Chambord, J (reprint author), ICL, Dept Pharm, Vandoeuvre Les Nancy, France.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019; 44 (3): 372

Abstract

What is known and Objective Two forms of ifosfamide are commercially available in France: HOLOXAN (R) (brand-name drug) and IFOSFAMIDE EG (R) (generic......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索